Christopher Heery
Chief Tech/Sci/R&D Officer at ARCELLX, INC.
Net worth: 459 234 $ as of 30/04/2024
Christopher Heery active positions
Companies | Position | Start | End |
---|---|---|---|
ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 01/04/2021 | - |
Career history of Christopher Heery
Former positions of Christopher Heery
Companies | Position | Start | End |
---|---|---|---|
PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 14/05/2019 | 23/04/2021 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 28/09/2016 | - |
Training of Christopher Heery
Brody School of Medicine | Doctorate Degree |
Duke University | Undergraduate Degree |
Statistics
International
United States | 6 |
Denmark | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
BAVARIAN NORDIC A/S | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
ARCELLX, INC. | Health Technology |
Private companies | 1 |
---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Stock Market
- Insiders
- Christopher Heery
- Experience